Stephanie Mills
About Stephanie Mills
Stephanie Mills is the Director, QC Network Leader in Analytical Science & Technology at Bristol Myers Squibb, with extensive experience in quality control roles across the biotechnology industry.
Title and Current Role
Stephanie Mills is the Director, QC Network Leader - Analytical Science & Technology at Bristol Myers Squibb. She has been leading the Quality Control Network in Analytical Science & Technology at the company since November 2019.
Work Experience
Stephanie Mills has extensive experience in the biotechnology industry, having held senior-level quality control roles across multiple companies. She served as Sr. Manager, QC Operations at Juno Therapeutics, Inc. for 10 months in 2019. From 2016 to 2019, she was the Sr. Manager of Quality Control at Kite Pharma. Prior to that, she was Manager of Quality Control at Dendreon for 5 years (2011-2016). She also worked as Sr. Manager of Quality Control & Bioanalytical Services at Altea Therapeutics for 10 years (2000-2010). Her earlier experience includes a role as a Research Biochemist at SpectRx (1999-2000) and as a Sr. Research Associate at Immunex Corporation (1990-1998).
Education and Expertise
Stephanie Mills holds a Bachelor of Science degree in Microbiology from Washington State University, having completed her studies from 1985 to 1990. She possesses expertise in Endotoxin testing and Good Laboratory Practice (GLP) within the biotechnology industry. In addition to her specialization in microbiology, she has experience working with medical devices.
Background in Microbiology
Stephanie Mills has a strong background in microbiology, supported by her academic credentials and extensive industry experience. She earned a Bachelor of Science degree in Microbiology from Washington State University. Her career has spanned various roles that leverage her microbiology expertise, including positions in quality control and bioanalytical services.